All About Multiple Sclerosis

More MS news articles for March 2003

Multiple sclerosis: new treatments will take on interferons

http://www.datamonitor.com/~a09612dbad874335ace431f4855df0a8~/all/news/product.asp?pid=431B5AD3-3091-4A82-A512-5D5087CA6576

14 Mar 2001

Several new multiple sclerosis treatments will be launched over the next seven years. Immunosuppressants will be first to hit the market and will take $210 million worth of sales in 2001, growing to $370 million by 2007. Monoclonal antibodies will have the largest market share, estimated to be worth $616 million in 2007 after only two years of launch. These drugs pose a threat to the current dominance of the interferon class.

* Marketed products will have a value of over $3 billion by 2007

* Potassium channel blockers will hit the market in 2006 with sales of $185 million, growing to $243 million the next year

* Other treatments introduced in 2006 will have a combined value of $296 in their initial year and $390 in 2007
 

© Copyright 2003, DataMonitor